The objective of this study was to access the prevalence of alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) histology in the general population, which had been otherwise diffi cult to access because of inherent misclassifi cation bias in surrogate marker studies and referral bias in patient case series. The interaction among rs738409, obesity, and alcohol remains controversial. This population-based autopsy study investigated the histological prevalence of ALD and NAFLD, and interactions among rs738409, obesity, and alcoholism.
INTRODUCTION
As many as half of the adults in the United States consume at least one alcoholic drink in a month, 5.1 % are heavy drinkers, and 15.5 % are binge drinkers ( 1 ) . On the other hand, 33.8 % of adults are obese ( 2 ) . Excessive alcohol intake and obesity are known to cause alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD), respectively. Th e histological spectrum of the two diseases is identical, which includes steatosis, steatohepatitis, and cirrhosis. Th e exact prevalence of ALD and NAFLD, however, is unknown. Although histology represents the reference standard for diagnosis, it is generally not feasible in population-based screening ( 3 ) . Most population-based crosssectional studies have utilized aminotransferase levels ( 4 ) or ultrasound ( 5 -7 ) . Th ese surrogate markers have limited sensitivity and specifi city for ALD and NAFLD, and cannot accurately diff erentiate steatosis from steatohepatitis or cirrhosis. Using
The Interaction of rs738409, Obesity, and Alcohol: A Population-Based Autopsy Study magnetic resonance spectroscopy, the most accurate noninvasive method, the Dallas Heart Study, estimated the prevalence of hepatic steatosis at 33.6 % ( 8 ). However, the prevalence of steatohepatitis and cirrhosis could not be assessed, and the prevalence of ALD in excessive drinkers could not be estimated because of relatively few excessive drinkers in their sample. Liver biopsy case series are generally from patients with signs and symptoms of liver disease who are followed and biopsied by gastroenterologists, and therefore limited by referral bias. In this study, the fi rst aim was to assess the prevalence of steatosis, steatohepatitis, and advance fi brosis among alcoholics and nonalcoholics, using a population-based autopsy study of patients who died in motor vehicle accidents.
Th ere are confl icting data on whether alcohol increases obesityassociated steatosis in an additive ( 9, 10 ) or a synergistic manner ( 11 ) , or, alternatively, has the opposite eff ect of reducing the incidence of obesity-associated steatosis ( 3 ) . Recently, the rs738409 C > G (I148M) single-nucleotide polymorphism in the PNPLA3 gene has been associated with hepatic steatosis. However, it remains unclear whether rs738409 is a simple risk factor for ALD and NAFLD, or it modifi es the eff ects of obesity and alcoholism. Our second aim was to explore the interaction among obesity, alcohol, and rs738409 towards NAFLD Activity Score (NAS) and fi brosis. Our a priori hypothesis is that the interaction may be synergistic, additive, or negative. Th e inclusion of unbiased subjects with various body mass index (BMI), with and without alcoholism, allowed assessment of interactions of rs738409, obesity, and alcoholism.
METHODS

Study sample
Th is study included adult (age ≥ 18 years) subjects who died as a result of motor vehicle accidents and underwent autopsy in 13 counties in Kansas (Shawnee, Douglas, Lyon, Chase, Allen, Neosho, Wilson, Woodson, Leavenworth, Johnson, Miami, Bourbon, and Linn) and four counties in Missouri (Johnson, Henry, Clinton, and Livingston) between January 2000 and August 2010. Forensic pathologists in these counties routinely performed liver biopsies and permanently stored histological specimens from all autopsy cases. Cases with a blood alcohol concentration (BAC) ≥ 0.08 % constituted the alcoholic group. A BAC ≥ 0.08 % typically results from ≥ 5 drinks in men or ≥ 4 drinks in women, and represents the threshold for binge drinking ( 12 ) as defi ned by the National Institute on Alcohol Abuse and Alcoholism. Although the prevalence of heavy drinkers and binge drinkers in this group has not been studied directly, the Behavioral Risk Factor Surveillance System of 2006 ( 13 ) estimated that 90 % of impaired driver episodes in the United States occurred in either heavy drinkers or binge drinkers. Th e nonalcoholic group, defi ned by an undetectable BAC, although not guaranteed to be free of alcoholics, represents a sample of the general population. Owing to the association between substance abuse and alcohol abuse, a negative drug screening is only required for inclusion in the nonalcoholic group. Subjects who died more than 24 h aft er hospital admission were excluded because their liver histology could have been aff ected by prolonged resuscitation ( 14 ) . Subjects with severe burns or decomposition were also excluded because measurement of BMI was not possible. Half of the male subjects and two-thirds of the alcoholic subjects were randomly selected for inclusion because of limited resources and the excess of nonalcoholic and male subjects available for analysis. Th is study was categorized with a " Determination of Not Human Subjects Research " from the Human Research Protection Program in Th e University of Kansas Medical Center.
Clinical data, genotype, and liver histology
At the time of each autopsy, the county forensic pathologists recorded the age, gender, race / ethnicity, BMI, toxicology, cause of death, and the time of death relative to the accident. Liver biopsy slides were stained with hematoxylin and eosin at the time of autopsy. Formaldehyde-fi xed and paraffi n-embedded liver tissue blocks were recovered for additional staining and genotyping. CK-8 / 18 staining was prepared from a 1:1 mixture of monoclonal mouse K8 Ab-8 Clone K8.8 and monoclonal mouse K18 Ab-1 Clone DC 10 (NeoMarkers, Fremont, CA), both 1:50 in Dako REAL antibody diluent. Trichrome staining was prepared using Richard-Allan Gomori Trichrome Stain Kit (Th ermo Fisher Scientifi c, Waltham, MA). Histology and immunohistochemistry were reviewed by a blinded pathologist (M.O.) and scored for NAS and fi brosis. Although there has not been any accepted pathological scoring system for alcohol-related steatosis, ballooning, and infl ammation, we adopted the Brunt classifi cation system ( 15 ) for grading both alcohol and non alcohol cases. Steatosis was recorded as grade 1 (5 -33 % ), grade 2 (34 -66 % ), or grade 3 ( > 66 % ). Owing to the large size of autopsy specimens compared with needle biopsy, all specimens had some degree of lobular infl ammation (i.e., ≥ grade 1). Th erefore, grade 1 was used as the reference in the ordinal logistic regression analysis. Th e aggregate NAS was calculated from the sum of steatosis, lobular infl ammation, and ballooning degeneration. Cases without steatosis were assigned an NAS of 0. One case with grade 2 lobular infl ammation without steatosis was excluded from the NAS analysis. None of the cases had ballooning without steatosis. Fibrosis staging was analyzed as stage 1a / b / c (zone 3 predominant perisinusoidal / pericellular fi brosis or portal fi brosis), stage 2 (plus periportal fi brosis), stage 3 (bridging fi brosis), and stage 4 (cirrhosis) in the ordinal logistic regression analysis. Th e diagnosis of steatohepatitis was based on the pathologist and hepatologist ' s overall assessment of steatosis, lobular infl ammation, ballooning degeneration, and perisinusoidal fi brosis ( 16 ) rather than a particular NAS cutoff . Th e pathologist and hepatologist were blinded to the clinical and demographic characteristics of the cases. Genomic DNA was extracted from formalin-fi xed and paraffi n-embedded tissue using phenol:chloroform:isopropyl alcohol at 25:24:1. A predesigned TaqMan probe (Assay ID: C_7241_10; Product number: 4351379; Applied Biosystems, Carlsbad, CA) was purchased for genotyping of rs738409. Real-time polymerase chain reaction was carried out using C1000 Th ermal Cycler (Bio-Rad, Hercules, CA) according to the manufacturer ' s protocol. Th e success rates of these assays were > 100.0 % .
Statistical analysis
Th e prevalences of steatosis, steatohepatitis, and cirrhosis in the alcoholic and nonalcoholic groups were calculated. To account for the ordinal nature of steatosis, lobular infl ammation, ballooning degeneration, and NAS score, ordinal logistic regression was used. Ordinal logistic regression cannot be used for fi brosis analysis owing to a violation of the proportional odds assumption. Th erefore, logistic regression was used to compare stage 0 -2 vs. 3 -4 fi brosis. Owing to the small number of rs738409 GG genotype, the GC and GG genotypes were grouped together as the " G allele carrier " and compared with the CC genotype ( 17 ) . Th e year 2000 census was used for direct age standardization ( 18 ) . All multivariable models included age, age 2 , gender, race, alcohol, BMI, and rs738409. Interactions among alcohol, BMI, and rs738409 were tested using interaction cross-terms (alcohol × BMI, alcohol × rs738409, BMI × rs738409). SAS 9.13 (SAS Institute, Cary, NC) was used for statistical analysis.
RESULTS
Between January 2000 and August 2010, 1034 adult motor vehicle accident autopsies were performed within the aforementioned counties in Kansas and Missouri. Aft er excluding nonalcoholics with positive drug screens, intermediate BAC, prolonged hospitalization, or severely burned and / or decomposed bodies, 736 cases were eligible for study inclusion. Of these cases, 68 % were men and 63 % were nonalcoholic. Half of the male cases and two-thirds of the alcoholic cases were randomly selected for inclusion ( n = 471). Th e fi nal analysis included 405 cases with tissue blocks available for staining and genotyping. Th ere were 170 alcoholic cases and 235 nonalcoholic cases. Th e distribution of the rs738409 genotype was 233 subjects with CC, 141 CG, and 31 GG ( Table 1 ) . Th e distribution of the rs738409 genotype by race and ethnicity was shown in Table 2 .
Potential bias
Although cases with hospitalization over 24 h have been excluded, the prevalence of steatosis does not diff er if the victim died at the scene. Th e prevalence of steatosis and fi brosis did not diff er if the victim is a driver, passenger, or pedestrian.
Effect of age and gender
Th e prevalence of steatosis, NAS, and fi brosis peaked between 45 and 54 years of age, and then decreased with advancing age ( Figure 1a, b ) . Th erefore, direct age standardization with the year 2000 census was used for prevalence estimates. Th e interaction term age 2 was highly signifi cant ( < 0.0001) and therefore included in all multivariable ordinal logistic regression analyses. Women 
NAS
Overall, the age-standardized prevalence of hepatic steatosis was 56 % in the alcoholic cases and 36 % in the nonalcoholic cases. Th e prevalence of steatohepatitis was 6 and 4 % , res pectively. Th e distribution of hepatic steatosis and NAS in the alcoholic, obesity, and genotype groups is shown in Figure 2 . Th e interaction terms among alcohol, BMI, and genotype were not signifi cant (alcohol × BMI, P = 0.56; alcohol × genotype, P = 0.67; BMI × genotype, P = 0.95). Th is study had 80 % power to detect an interaction if the interaction carried an additional fourfold odds. Th e rs738409 GC or GG genotypes were associated with 1.9-fold odds (95 % CI, 1.2 -2.9) of a higher NAS. When GC and GG were analyzed separately, there appears to be a small incremental increase in odds from GC (OR 1.8) to GG (OR 2.2). Alcohol had 3.5-fold odds (95 % CI, 2.0 -5.9), while every 5-unit increase in BMI had 1.9-fold odds (95 % CI 1.7 -2.5).
In terms of the point estimate of individual histological features comprising the NAS, alcohol was associated with 3.6-fold odds for macrovesicular steatosis, 2.9-fold odds for lobular infl ammation and 3.1-fold odds for ballooning degeneration. Every 5-unit increase in BMI was associated with 2.2-fold odds for macro vesicular steatosis, 1.8-fold odds for lobular infl ammation and 1.6-fold odds for ballooning degeneration. G allele was associated with 2.1-fold odds for macrovesicular steatosis, 1.8-fold odds for lobular infl ammation and 1.1-fold odds for ballooning degeneration. 
DISCUSSION
Th is study provided an assessment of fatty liver histology in the general population from an autopsy perspective, which was not possible with previous surrogate marker studies and patient case series. Th e prevalences of hepatic steatosis, steatohepatitis, and advanced fi brosis were 56, 6, and 18 % in alcoholics, and 36, 4, and 6 % among nonalcoholics, respectively. Th e association of NAS was diff erent from that of fi brosis. For NAS, rs738409, BMI, and alcohol were simply additive. For fi brosis, alcohol and BMI demonstrated a statistically signifi cant negative interaction. Th e rs738409 GC / GG genotype was associated with more advanced fi brosis and less early fi brosis. Both NAS score and fi brosis peaked between 45 and 54 years of age, and then decreased with advancing age.
In the Dallas Heart Study, the prevalence of hepatic steatosis estimated by magnetic resonance spectroscopy was found to be 34 % ( 8 ), which was very similar to our estimate of 36 % in nonalcoholics. In addition, our study estimated a steatohepatitis prevalence of 4 % and advanced fi brosis at 6 % . Th e prevalence in the excessive drinkers could not be estimated because excessive drinkers comprised only 6 % of the Dallas Heart Study sample. Biopsy case series of heavy drinkers estimated the prevalences of steatosis, steatohepatitis, and cirrhosis to be 58 -100, 10 -34, and 10 -34 % , respectively ( 19 -22 ) , which were slightly higher than our estimates. In comparison, population-based screening with ultrasound typically fi nds a prevalence of < 20 % for steatosis among heavy drinkers ( 3,5 -7 ) . Th e diff erence may result from selection bias in the biopsy case series, lack of sensitivity of the ultrasound examination, and the 10 % misclassifi cation bias in our autopsy study.
Th e interaction between obesity and alcohol in causing hepatic steatosis remains controversial. A cross-sectional study in Finland showed an additive interaction between alcohol consumption and obesity in the prevalence of liver enzyme abnormalities ( 9 ) . A UK study showed an additive eff ect between heavy drinking and obesity in the incidence of cirrhosis and liver disease mortality ( 10 ) . On the other hand, a cross-sectional study in northern Italy showed a negative interaction between alcohol and obesity in the prevalence of ultrasound and liver enzyme abnormalities ( 3 ) . A US study showed that obesity may decrease the alcohol threshold for liver injury ( 4 ). Th is study showed an additive interaction between
Fibrosis
Th e age-adjusted prevalence of hepatic fi brosis of any stage was 42 % in the alcoholic cases and 30 % in the nonalcoholic cases, while the age-adjusted prevalence of advanced fi brosis was 18 % and 6 % , respectively. However, the rs738409 CC genotype was not associated with hepatic fi brosis (OR, 1.2; 95 % CI, 0.76 -2.0). Th e eff ect of alcohol and BMI was also similar across rs738409 genotypes.
Th e interaction term alcohol × BMI was statistically signifi cant ( P = 0.036). Every 5-unit increase in BMI was associated with 2.2 times the odds (95 % CI, 1.5 -2.5) of fi brosis in the nonalcohol group, but was not associated with increased fi brosis in the alcohol group (OR, 0.84; 95 % CI, 0.66 -3.1). Figure 3 outlines the agestandardized prevalence of hepatic fi brosis by alcohol and obesity. Th e rs738409 GC / GG genotype was not associated with hepatic fi brosis (OR, 1.2; 95 % CI, 0.76 -2.0) owing to a higher prevalence of stage 1 and 2 fi brosis in CC genotype and stage 3 and 4 fi brosis in GC / GG genotype ( Figure 4 ) , which violated the proportional odds assumption of the ordinal regression model (cumulative model test, P = 0.0004). When compared across stage 0 -2 vs. 3 -4 fi brosis, the rs738409 GC / GG genotype was associated with 3.2 times the odds (95 % CI, 1.4 -7.3).
Other liver disease histologies
Th ere were 12 cases with grade 1 portal infl ammation without steatosis. Compared with normal liver, isolated portal infl ammation was associated with rs738409 GC / GG genotype ( P = 0.04), but not BMI or alcohol. Th ese 12 cases were consistent with viral hepatitis. One patient had grade 2 lobular infl ammation without steatosis. Forty-four patients had fi brosis without steatosis (stage 1a / b = 14; stage 1c = 12; stage 2 = 10; stage 3 = 5; and stage 4 = 3). Isolated fi brosis was not associated with rs738409 genotype, BMI, or alcohol. Th ere were 19 cases of stage 1c portal-only fi brosis: 7 were associated with steatosis (grade 1 = 4; grade 2 = 2; and grade 3 = 1) and 12 were not. Stage 1c fi brosis was associated with BMI ( P = 0.01), but not genotype or alcohol. 
LIVER
The Interaction of rs738409, Obesity, and Alcohol alcohol and obesity towards NAS (steatosis, infl ammation, and cell injury), but a statistically signifi cant negative interaction between alcohol and obesity towards fi brosis. Th e fi nding that obese alcoholics had less fi brosis than obese nonalcoholics suggested a possible benefi cial eff ect of alcohol for this subgroup. Our fi nding of negative interaction should be interpreted as a mechanistic clue that alcohol may have antifi brotic properties. Along with other studies that have suggested an antifi brotic property of alcohol ( 23 -25 ) , our fi nding justifi es a pharmacological investigation into the antifi brotic mechanism of alcohol, and how this mechanism can be activated without alcohol.
Recently, a genome-wide association scan of the nonsynonymous single-nucleotide polymorphisms in the Dallas Heart Study participants identified that the I148M allele (rs738409) in the PNPLA3 gene was strongly associated with increased hepatic triglycerides as measured by magnetic spectroscopy ( 26 ) . Little information exists in the literature as to whether rs738409 simply represents a risk factor for steatosis, or the gene modifies the effects of obesity and alcoholism toward steatosis. In a case -control study of Hispanics with alcohol dependence ( 27 ) , those with cirrhosis were more likely to have the G allele than those with apparently normal liver function. In another case -control study of European Caucasian ( 17 ) patients undergoing liver biopsy for suspected ALD vs. healthy social workers, the G allele was associated with ALD and cirrhosis in ALD. However, these two findings did not differentiate whether rs738409 is a simple risk for hepatic steatosis, or if it modifies the effects of obesity and alcoholism in causing hepatic steatosis. This study included an unbiased sample with subjects of various BMI, with and without alcoholism, to study the interactions of rs738409, obesity, and alcoholism. Our study showed an additive interaction among rs738409, obesity, and alcohol towards NAS. Those with the rs738409 G allele are especially at risk if they are obese or drink alcohol excessively.
By far, the most critical issue concerning the validity of this study is the misclassifi cation bias in the alcoholic and nonalcoholic group. All cases in the alcoholic group fulfi lled the criteria for binge drinking at the time of death, and the alcohol use was in a situation that was physically hazardous. According to the Diagnostic and Statistical Manual of Mental Disorders IV, the diagnosis of alcohol abuse can be made based on " recurrent alcohol use in situations in which it is physically hazardous. " Th e recurrent nature of the drinking pattern in this group has been supported by Behavioral Risk Factor Surveillance System 2006 data ( 13 ) , which estimated that alcohol-impaired drivers in the United States comprised of 33.9 % heavy drinkers with binge drinking, 49.4 % nonheavy drinkers with binge drinking, 1 % heavy drinkers without binge drinking, and 15.7 % nonheavy drinkers without binge drinking. When weighted by alcoholimpaired drinking episodes, only 10.6 % of alcohol-impaired driving episodes were attributed to nonheavy drinkers without binge drinking. Behavioral Risk Factor Surveillance System did not set a minimum alcohol threshold to be considered for alcohol-impaired drivers, while our study used BAC ≥ 0.08 % as the inclusion criteria for the alcohol group. On the other hand, the Behavioral Risk Factor Surveillance System defi nition of heavy drinking (also the NIAAA defi nition) was > 1 drink per day for women and > 2 drinks per day for men ( 28 ) , which was lower than the usual criteria for ALD. Still, we anticipate a misclassifi cation bias of 10.6 % in the alcoholic group. Th e nonalcoholic group should be similar to the general population, with 15.3 % heavy and / or binge drinkers ( 1 ) . Unlike case series, the alcohol frequency and amount cannot be quantifi ed. Nevertheless, a BAC ≥ 0.08 % typically results from ≥ 5 drinks in men or ≥ 4 drinks in women.
Th is study design had a number of important characteristics that allowed for an accurate assessment of the prevalence of hepatic steatosis. Histology is currently the reference standard for diagnosis of ALD and NAFLD. Autopsy studies with liver histology have been used to estimate the prevalence of fatty liver disease in West India ( 29 ) , Toronto ( 30 ) , and Northwestern Greece ( 31 ) . In contrast to this study, nonaccidental death was included in previous studies, which may have resulted in selection bias as a large proportion of patients died of ischemic heart disease, and 70 % of those had steatosis or steatohepatitis. In a San Diego county pediatric autopsy study ( 14 ) , only cases of accidental death, homicide, and suicide were included. In an unpublished pilot autopsy study in Olmsted County, MN comparing accidental, homicidal, and suicidal cases, homicide and suicide cases were found to have a substantially higher prevalence of hepatic steatosis than the accidental cases. On the basis of these data, we chose to only include accidental cases in this study. Furthermore, this study excluded cases with hospitalization exceeding 1 day to eliminate the impact of prolonged resuscitation on liver histology. Th ese features in the methodology allowed this study to circumvent the limitations of previous studies and to measure the prevalence of hepatic steatosis with minimal bias.
In conclusion, this study reported the prevalence of fatty liver histology in the general population, stratifi ed by age, BMI, alcoholism, and rs738409 genotype. Th e fi nding of additive interaction among rs738409, obesity, and alcohol towards NAS may be useful in targeting preventative care to patients at highest risk for ALD. Th e negative interaction between alcohol and obesity towards fi brosis justifi es future research to explore potentially antifi brotic mechanism of alcohol, and may lead to improved treatment to prevent fi brosis. 
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